Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in their lifetime1Previous studies have shown that VETMEDIN® could help improve ...

Since VETMEDIN was first introduced 25 years ago, dogs and their owners around the world have enjoyed more than 1 million years of additional life to love. VETMEDIN chewable tablets are approved for ...

COVID-19 is proving to take a toll on some pets, as a potentially life-saving medication for dogs with heart problems is in short supply because of production issues tied to the pandemic.

Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in their lifetime1Previous studies have shown that VETMEDIN® could help improve ...

Boehringer Ingelheim, a global leader in animal health, launched VETMEDIN® Solution, the first oral solution approved by the U.S. Food and Drug Administration (FDA) for the management of ...

Boehringer Ingelheim also offers VETMEDIN ®-CA1 (pimobendan), which has FDA conditional approval for use in dogs with Stage B2 preclinical MMVD - which may enable a delay in the onset of heart ...

DULUTH, Ga, Nov. 23, 2024 /PRNewswire/ -- Boehringer Ingelheim, a global leader in animal health, launched VETMEDIN ® Solution, the first oral solution approved by the U.S. Food and Drug ...